The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context

IntroductionGlioblastoma multiforme (GBM) pathobiology is characterized by its significant induction of immunosuppression within the tumor microenvironment, predominantly mediated by immunosuppressive tumor-associated myeloid cells (TAMCs). Myeloid cells play a pivotal role in shaping the GBM microe...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Tzu-Yi Chia, Leah K. Billingham, Lauren Boland, Joshua L. Katz, Victor A. Arrieta, Jack Shireman, Aurora-Lopez Rosas, Susan L. DeLay, Kaylee Zillinger, Yuheng Geng, Jeandre Kruger, Caylee Silvers, Hanxiang Wang, Gustavo Ignacio Vazquez Cervantes, David Hou, Si Wang, Hanxiao Wan, Adam Sonabend, Peng Zhang, Catalina Lee-Chang, Jason Miska
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2024-01-01
Sarja:	Frontiers in Immunology
Aiheet:	glioblastoma CXCL16 CXCR6 immunotherapy myeloid cells
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1331287/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!